ALIGOS THERAPEUTICS ($ALGS) posted quarterly earnings results on Tuesday, May 6th. The company reported earnings of -$2.11 per share, beating estimates of -$2.85 by $0.74. The company also reported revenue of $310,000, missing estimates of $339,996 by $-29,996.
You can see Quiver Quantitative's $ALGS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ALIGOS THERAPEUTICS Hedge Fund Activity
We have seen 0 institutional investors add shares of ALIGOS THERAPEUTICS stock to their portfolio, and 1 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AVIOR WEALTH MANAGEMENT, LLC removed 80 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $660
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
